Sudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price band for the offer is set at Rs 563–593, with 50% of shares reserved for QIBs, 15% for NIIs and 35% for retail investors. With a GMP hovering around 16% ahead of the launch, the IPO is generating significant buzz in the unlisted market.